Principal Financial Group
LJPC

Principal Financial Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Principal Financial Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-84,296
Closed -$340K – 2507
2020
Q3 		$340K Buy
84,296
+36,788
+77% +$152K ﹤0.01% 2106
2020
Q2 		$202K Buy
+47,508
New +$289K ﹤0.01% 2187

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group's LJPC Position: Q4 2020 in Review

Principal Financial Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2020, closing a stake of 84,296 shares — an estimated $340K sold.

Principal Financial Group first reported a position in LJPC in Q2 2020 and held it in 2 quarters. The position peaked at $340K in Q3 2020. 65 funds tracked by Wall St. Rank hold LJPC as of Q4 2020.

  • Principal Financial Group reported no remaining La Jolla Pharmaceutical Company position as of Q4 2020 after selling out during the quarter.
  • Principal Financial Group sold 84,296 La Jolla Pharmaceutical Company shares in Q4 2020, an estimated $340K.
  • Principal Financial Group first reported a position in La Jolla Pharmaceutical Company in Q2 2020 and held it in 2 quarters.
  • Principal Financial Group's La Jolla Pharmaceutical Company position peaked at $340K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2020.

Based on Principal Financial Group's 13F filing for Q4 2020, filed 8 Feb 2021.